Goodfelllow Pharma Corp. pioneered in introducing to the Philippines a breakthrough Chinese herbal medicine known as Zilongjin, which have been proven as adjuvant therapy for cancer with studies conducted at the Beijing Cancer Hospital with cancer patients from foreign countries located across Europe, America, Asia and Australia.
Goodfellow Pharma Corp. is one among the leaders of pharmaceutical companies, marketing oncology, nephrology, and hematology drugs and is looking forward in introducing generic products from China in response to the call of the Philippines Government to provide quality, effective and affordable medicine to Filipinos.
